ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tenofovir Fumarate Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29B16565
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Tenofovir Fumarate Market Research Report 2024
BUY CHAPTERS

Global Tenofovir Fumarate Market Research Report 2025

Code: QYRE-Auto-29B16565
Report
September 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Toronto Research Chemicals
Boc Sciences
Glaxo Smithkline
Gilead Sciences
Emcure Pharmaceuticals Limited
Natco Pharma
Viatris
HBCChem
T&W Group
Qilu Pharmaceutical Co. Ltd.
Shang Enda Biotechnology
Huilun Pharmaceutical Co., Ltd
Hefei Topway Biotechnology Co., Ltd
Supor Pharmaceutical Co., Ltd
Carelife Pharmaceutical Co., Ltd
Anke Hengyi Pharmaceutical Co., Ltd
T&W Group

Tenofovir Fumarate Market

The global market for Tenofovir Fumarate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
It is an antiretroviral drug commonly used to treat human immunodeficiency virus (HIV) infection and hepatitis B virus (HBV) infection. It is a nucleoside reverse transcriptase inhibitor that blocks the replication and spread of viruses by inhibiting the reverse transcriptase activity of HIV and HBV viruses. Common trade names of tenofovir fumarate include terifovir (TDF), cyclolivir (Viread), etc. It is usually available as oral tablets, each containing a specified dose of tenofovir fumarate. Tenofovir fumarate is commonly used in antiretroviral treatment regimens for HIV treatment. It can be used alone or in combination with other antiretroviral drugs to slow down disease progression in HIV-infected patients and reduce the presence of the virus in the body. level, so as to achieve the purpose of controlling the disease.
North American market for Tenofovir Fumarate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tenofovir Fumarate is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tenofovir Fumarate include Toronto Research Chemicals, BOC Sciences, Glaxo SmithKline, Gilead Sciences, Emcure Pharmaceuticals Limited, Natco Pharma, Viatris Inc, HBCChem, Shang Enda Biotechnology, T&W Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tenofovir Fumarate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tenofovir Fumarate.
The Tenofovir Fumarate market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tenofovir Fumarate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tenofovir Fumarate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tenofovir Fumarate Market Report

Report Metric Details
Report Name Tenofovir Fumarate Market
Segment by Type
  • 30 Pcs/Box
  • 10 Pcs/Box
  • Others
Segment by Application
  • Hospital
  • Scientific Research Institutions
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Toronto Research Chemicals, BOC Sciences, Glaxo SmithKline, Gilead Sciences, Emcure Pharmaceuticals Limited, Natco Pharma, Viatris Inc, HBCChem, Shang Enda Biotechnology, T&W Group, Huilun Pharmaceutical Co., Ltd, Hefei Topway Biotechnology Co., Ltd, Supor Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd, Carelife Pharmaceutical Co., Ltd, Anke Hengyi Pharmaceutical Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tenofovir Fumarate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tenofovir Fumarate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tenofovir Fumarate Market report?

Ans: The main players in the Tenofovir Fumarate Market are Toronto Research Chemicals, BOC Sciences, Glaxo SmithKline, Gilead Sciences, Emcure Pharmaceuticals Limited, Natco Pharma, Viatris Inc, HBCChem, Shang Enda Biotechnology, T&W Group, Huilun Pharmaceutical Co., Ltd, Hefei Topway Biotechnology Co., Ltd, Supor Pharmaceutical Co., Ltd, Qilu Pharmaceutical Co., Ltd, Carelife Pharmaceutical Co., Ltd, Anke Hengyi Pharmaceutical Co., Ltd

What are the Application segmentation covered in the Tenofovir Fumarate Market report?

Ans: The Applications covered in the Tenofovir Fumarate Market report are Hospital, Scientific Research Institutions

What are the Type segmentation covered in the Tenofovir Fumarate Market report?

Ans: The Types covered in the Tenofovir Fumarate Market report are 30 Pcs/Box, 10 Pcs/Box, Others

1 Tenofovir Fumarate Market Overview
1.1 Product Definition
1.2 Tenofovir Fumarate by Type
1.2.1 Global Tenofovir Fumarate Market Value Comparison by Type (2024 VS 2031)
1.2.2 30 Pcs/Box
1.2.3 10 Pcs/Box
1.2.4 Others
1.3 Tenofovir Fumarate by Application
1.3.1 Global Tenofovir Fumarate Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Scientific Research Institutions
1.4 Global Tenofovir Fumarate Market Size Estimates and Forecasts
1.4.1 Global Tenofovir Fumarate Revenue 2020-2031
1.4.2 Global Tenofovir Fumarate Sales 2020-2031
1.4.3 Global Tenofovir Fumarate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tenofovir Fumarate Market Competition by Manufacturers
2.1 Global Tenofovir Fumarate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tenofovir Fumarate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tenofovir Fumarate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tenofovir Fumarate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tenofovir Fumarate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tenofovir Fumarate, Product Type & Application
2.7 Global Key Manufacturers of Tenofovir Fumarate, Date of Enter into This Industry
2.8 Global Tenofovir Fumarate Market Competitive Situation and Trends
2.8.1 Global Tenofovir Fumarate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tenofovir Fumarate Players Market Share by Revenue
2.8.3 Global Tenofovir Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tenofovir Fumarate Market Scenario by Region
3.1 Global Tenofovir Fumarate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tenofovir Fumarate Sales by Region: 2020-2031
3.2.1 Global Tenofovir Fumarate Sales by Region: 2020-2025
3.2.2 Global Tenofovir Fumarate Sales by Region: 2026-2031
3.3 Global Tenofovir Fumarate Revenue by Region: 2020-2031
3.3.1 Global Tenofovir Fumarate Revenue by Region: 2020-2025
3.3.2 Global Tenofovir Fumarate Revenue by Region: 2026-2031
3.4 North America Tenofovir Fumarate Market Facts & Figures by Country
3.4.1 North America Tenofovir Fumarate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tenofovir Fumarate Sales by Country (2020-2031)
3.4.3 North America Tenofovir Fumarate Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tenofovir Fumarate Market Facts & Figures by Country
3.5.1 Europe Tenofovir Fumarate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tenofovir Fumarate Sales by Country (2020-2031)
3.5.3 Europe Tenofovir Fumarate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tenofovir Fumarate Market Facts & Figures by Region
3.6.1 Asia Pacific Tenofovir Fumarate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tenofovir Fumarate Sales by Region (2020-2031)
3.6.3 Asia Pacific Tenofovir Fumarate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tenofovir Fumarate Market Facts & Figures by Country
3.7.1 Latin America Tenofovir Fumarate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tenofovir Fumarate Sales by Country (2020-2031)
3.7.3 Latin America Tenofovir Fumarate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tenofovir Fumarate Market Facts & Figures by Country
3.8.1 Middle East and Africa Tenofovir Fumarate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tenofovir Fumarate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tenofovir Fumarate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tenofovir Fumarate Sales by Type (2020-2031)
4.1.1 Global Tenofovir Fumarate Sales by Type (2020-2025)
4.1.2 Global Tenofovir Fumarate Sales by Type (2026-2031)
4.1.3 Global Tenofovir Fumarate Sales Market Share by Type (2020-2031)
4.2 Global Tenofovir Fumarate Revenue by Type (2020-2031)
4.2.1 Global Tenofovir Fumarate Revenue by Type (2020-2025)
4.2.2 Global Tenofovir Fumarate Revenue by Type (2026-2031)
4.2.3 Global Tenofovir Fumarate Revenue Market Share by Type (2020-2031)
4.3 Global Tenofovir Fumarate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tenofovir Fumarate Sales by Application (2020-2031)
5.1.1 Global Tenofovir Fumarate Sales by Application (2020-2025)
5.1.2 Global Tenofovir Fumarate Sales by Application (2026-2031)
5.1.3 Global Tenofovir Fumarate Sales Market Share by Application (2020-2031)
5.2 Global Tenofovir Fumarate Revenue by Application (2020-2031)
5.2.1 Global Tenofovir Fumarate Revenue by Application (2020-2025)
5.2.2 Global Tenofovir Fumarate Revenue by Application (2026-2031)
5.2.3 Global Tenofovir Fumarate Revenue Market Share by Application (2020-2031)
5.3 Global Tenofovir Fumarate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Toronto Research Chemicals
6.1.1 Toronto Research Chemicals Company Information
6.1.2 Toronto Research Chemicals Description and Business Overview
6.1.3 Toronto Research Chemicals Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Toronto Research Chemicals Tenofovir Fumarate Product Portfolio
6.1.5 Toronto Research Chemicals Recent Developments/Updates
6.2 BOC Sciences
6.2.1 BOC Sciences Company Information
6.2.2 BOC Sciences Description and Business Overview
6.2.3 BOC Sciences Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BOC Sciences Tenofovir Fumarate Product Portfolio
6.2.5 BOC Sciences Recent Developments/Updates
6.3 Glaxo SmithKline
6.3.1 Glaxo SmithKline Company Information
6.3.2 Glaxo SmithKline Description and Business Overview
6.3.3 Glaxo SmithKline Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Glaxo SmithKline Tenofovir Fumarate Product Portfolio
6.3.5 Glaxo SmithKline Recent Developments/Updates
6.4 Gilead Sciences
6.4.1 Gilead Sciences Company Information
6.4.2 Gilead Sciences Description and Business Overview
6.4.3 Gilead Sciences Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gilead Sciences Tenofovir Fumarate Product Portfolio
6.4.5 Gilead Sciences Recent Developments/Updates
6.5 Emcure Pharmaceuticals Limited
6.5.1 Emcure Pharmaceuticals Limited Company Information
6.5.2 Emcure Pharmaceuticals Limited Description and Business Overview
6.5.3 Emcure Pharmaceuticals Limited Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Emcure Pharmaceuticals Limited Tenofovir Fumarate Product Portfolio
6.5.5 Emcure Pharmaceuticals Limited Recent Developments/Updates
6.6 Natco Pharma
6.6.1 Natco Pharma Company Information
6.6.2 Natco Pharma Description and Business Overview
6.6.3 Natco Pharma Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Natco Pharma Tenofovir Fumarate Product Portfolio
6.6.5 Natco Pharma Recent Developments/Updates
6.7 Viatris Inc
6.7.1 Viatris Inc Company Information
6.7.2 Viatris Inc Description and Business Overview
6.7.3 Viatris Inc Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Viatris Inc Tenofovir Fumarate Product Portfolio
6.7.5 Viatris Inc Recent Developments/Updates
6.8 HBCChem
6.8.1 HBCChem Company Information
6.8.2 HBCChem Description and Business Overview
6.8.3 HBCChem Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.8.4 HBCChem Tenofovir Fumarate Product Portfolio
6.8.5 HBCChem Recent Developments/Updates
6.9 Shang Enda Biotechnology
6.9.1 Shang Enda Biotechnology Company Information
6.9.2 Shang Enda Biotechnology Description and Business Overview
6.9.3 Shang Enda Biotechnology Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shang Enda Biotechnology Tenofovir Fumarate Product Portfolio
6.9.5 Shang Enda Biotechnology Recent Developments/Updates
6.10 T&W Group
6.10.1 T&W Group Company Information
6.10.2 T&W Group Description and Business Overview
6.10.3 T&W Group Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.10.4 T&W Group Tenofovir Fumarate Product Portfolio
6.10.5 T&W Group Recent Developments/Updates
6.11 Huilun Pharmaceutical Co., Ltd
6.11.1 Huilun Pharmaceutical Co., Ltd Company Information
6.11.2 Huilun Pharmaceutical Co., Ltd Description and Business Overview
6.11.3 Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.11.5 Huilun Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Hefei Topway Biotechnology Co., Ltd
6.12.1 Hefei Topway Biotechnology Co., Ltd Company Information
6.12.2 Hefei Topway Biotechnology Co., Ltd Description and Business Overview
6.12.3 Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Product Portfolio
6.12.5 Hefei Topway Biotechnology Co., Ltd Recent Developments/Updates
6.13 Supor Pharmaceutical Co., Ltd
6.13.1 Supor Pharmaceutical Co., Ltd Company Information
6.13.2 Supor Pharmaceutical Co., Ltd Description and Business Overview
6.13.3 Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.13.5 Supor Pharmaceutical Co., Ltd Recent Developments/Updates
6.14 Qilu Pharmaceutical Co., Ltd
6.14.1 Qilu Pharmaceutical Co., Ltd Company Information
6.14.2 Qilu Pharmaceutical Co., Ltd Description and Business Overview
6.14.3 Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.14.5 Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
6.15 Carelife Pharmaceutical Co., Ltd
6.15.1 Carelife Pharmaceutical Co., Ltd Company Information
6.15.2 Carelife Pharmaceutical Co., Ltd Description and Business Overview
6.15.3 Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.15.5 Carelife Pharmaceutical Co., Ltd Recent Developments/Updates
6.16 Anke Hengyi Pharmaceutical Co., Ltd
6.16.1 Anke Hengyi Pharmaceutical Co., Ltd Company Information
6.16.2 Anke Hengyi Pharmaceutical Co., Ltd Description and Business Overview
6.16.3 Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Product Portfolio
6.16.5 Anke Hengyi Pharmaceutical Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tenofovir Fumarate Industry Chain Analysis
7.2 Tenofovir Fumarate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tenofovir Fumarate Production Mode & Process Analysis
7.4 Tenofovir Fumarate Sales and Marketing
7.4.1 Tenofovir Fumarate Sales Channels
7.4.2 Tenofovir Fumarate Distributors
7.5 Tenofovir Fumarate Customer Analysis
8 Tenofovir Fumarate Market Dynamics
8.1 Tenofovir Fumarate Industry Trends
8.2 Tenofovir Fumarate Market Drivers
8.3 Tenofovir Fumarate Market Challenges
8.4 Tenofovir Fumarate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Toronto Research Chemicals
Boc Sciences
Glaxo Smithkline
Gilead Sciences
Emcure Pharmaceuticals Limited
Natco Pharma
Viatris
HBCChem
T&W Group
Qilu Pharmaceutical Co. Ltd.
Shang Enda Biotechnology
Huilun Pharmaceutical Co., Ltd
Hefei Topway Biotechnology Co., Ltd
Supor Pharmaceutical Co., Ltd
Carelife Pharmaceutical Co., Ltd
Anke Hengyi Pharmaceutical Co., Ltd
T&W Group
List of Tables
 Table 1. Global Tenofovir Fumarate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tenofovir Fumarate Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tenofovir Fumarate Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tenofovir Fumarate Sales (Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tenofovir Fumarate Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tenofovir Fumarate Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tenofovir Fumarate Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tenofovir Fumarate Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tenofovir Fumarate, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tenofovir Fumarate, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tenofovir Fumarate, Product Type & Application
 Table 12. Global Key Manufacturers of Tenofovir Fumarate, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tenofovir Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Fumarate as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tenofovir Fumarate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tenofovir Fumarate Sales by Region (2020-2025) & (Units)
 Table 18. Global Tenofovir Fumarate Sales Market Share by Region (2020-2025)
 Table 19. Global Tenofovir Fumarate Sales by Region (2026-2031) & (Units)
 Table 20. Global Tenofovir Fumarate Sales Market Share by Region (2026-2031)
 Table 21. Global Tenofovir Fumarate Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tenofovir Fumarate Revenue Market Share by Region (2020-2025)
 Table 23. Global Tenofovir Fumarate Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tenofovir Fumarate Revenue Market Share by Region (2026-2031)
 Table 25. North America Tenofovir Fumarate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tenofovir Fumarate Sales by Country (2020-2025) & (Units)
 Table 27. North America Tenofovir Fumarate Sales by Country (2026-2031) & (Units)
 Table 28. North America Tenofovir Fumarate Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tenofovir Fumarate Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tenofovir Fumarate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tenofovir Fumarate Sales by Country (2020-2025) & (Units)
 Table 32. Europe Tenofovir Fumarate Sales by Country (2026-2031) & (Units)
 Table 33. Europe Tenofovir Fumarate Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tenofovir Fumarate Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tenofovir Fumarate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tenofovir Fumarate Sales by Region (2020-2025) & (Units)
 Table 37. Asia Pacific Tenofovir Fumarate Sales by Region (2026-2031) & (Units)
 Table 38. Asia Pacific Tenofovir Fumarate Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tenofovir Fumarate Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tenofovir Fumarate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tenofovir Fumarate Sales by Country (2020-2025) & (Units)
 Table 42. Latin America Tenofovir Fumarate Sales by Country (2026-2031) & (Units)
 Table 43. Latin America Tenofovir Fumarate Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tenofovir Fumarate Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tenofovir Fumarate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tenofovir Fumarate Sales by Country (2020-2025) & (Units)
 Table 47. Middle East and Africa Tenofovir Fumarate Sales by Country (2026-2031) & (Units)
 Table 48. Middle East and Africa Tenofovir Fumarate Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tenofovir Fumarate Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tenofovir Fumarate Sales (Units) by Type (2020-2025)
 Table 51. Global Tenofovir Fumarate Sales (Units) by Type (2026-2031)
 Table 52. Global Tenofovir Fumarate Sales Market Share by Type (2020-2025)
 Table 53. Global Tenofovir Fumarate Sales Market Share by Type (2026-2031)
 Table 54. Global Tenofovir Fumarate Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tenofovir Fumarate Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tenofovir Fumarate Revenue Market Share by Type (2020-2025)
 Table 57. Global Tenofovir Fumarate Revenue Market Share by Type (2026-2031)
 Table 58. Global Tenofovir Fumarate Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tenofovir Fumarate Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tenofovir Fumarate Sales (Units) by Application (2020-2025)
 Table 61. Global Tenofovir Fumarate Sales (Units) by Application (2026-2031)
 Table 62. Global Tenofovir Fumarate Sales Market Share by Application (2020-2025)
 Table 63. Global Tenofovir Fumarate Sales Market Share by Application (2026-2031)
 Table 64. Global Tenofovir Fumarate Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tenofovir Fumarate Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tenofovir Fumarate Revenue Market Share by Application (2020-2025)
 Table 67. Global Tenofovir Fumarate Revenue Market Share by Application (2026-2031)
 Table 68. Global Tenofovir Fumarate Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tenofovir Fumarate Price (US$/Unit) by Application (2026-2031)
 Table 70. Toronto Research Chemicals Company Information
 Table 71. Toronto Research Chemicals Description and Business Overview
 Table 72. Toronto Research Chemicals Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Toronto Research Chemicals Tenofovir Fumarate Product
 Table 74. Toronto Research Chemicals Recent Developments/Updates
 Table 75. BOC Sciences Company Information
 Table 76. BOC Sciences Description and Business Overview
 Table 77. BOC Sciences Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BOC Sciences Tenofovir Fumarate Product
 Table 79. BOC Sciences Recent Developments/Updates
 Table 80. Glaxo SmithKline Company Information
 Table 81. Glaxo SmithKline Description and Business Overview
 Table 82. Glaxo SmithKline Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Glaxo SmithKline Tenofovir Fumarate Product
 Table 84. Glaxo SmithKline Recent Developments/Updates
 Table 85. Gilead Sciences Company Information
 Table 86. Gilead Sciences Description and Business Overview
 Table 87. Gilead Sciences Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Gilead Sciences Tenofovir Fumarate Product
 Table 89. Gilead Sciences Recent Developments/Updates
 Table 90. Emcure Pharmaceuticals Limited Company Information
 Table 91. Emcure Pharmaceuticals Limited Description and Business Overview
 Table 92. Emcure Pharmaceuticals Limited Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Emcure Pharmaceuticals Limited Tenofovir Fumarate Product
 Table 94. Emcure Pharmaceuticals Limited Recent Developments/Updates
 Table 95. Natco Pharma Company Information
 Table 96. Natco Pharma Description and Business Overview
 Table 97. Natco Pharma Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Natco Pharma Tenofovir Fumarate Product
 Table 99. Natco Pharma Recent Developments/Updates
 Table 100. Viatris Inc Company Information
 Table 101. Viatris Inc Description and Business Overview
 Table 102. Viatris Inc Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Viatris Inc Tenofovir Fumarate Product
 Table 104. Viatris Inc Recent Developments/Updates
 Table 105. HBCChem Company Information
 Table 106. HBCChem Description and Business Overview
 Table 107. HBCChem Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. HBCChem Tenofovir Fumarate Product
 Table 109. HBCChem Recent Developments/Updates
 Table 110. Shang Enda Biotechnology Company Information
 Table 111. Shang Enda Biotechnology Description and Business Overview
 Table 112. Shang Enda Biotechnology Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shang Enda Biotechnology Tenofovir Fumarate Product
 Table 114. Shang Enda Biotechnology Recent Developments/Updates
 Table 115. T&W Group Company Information
 Table 116. T&W Group Description and Business Overview
 Table 117. T&W Group Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. T&W Group Tenofovir Fumarate Product
 Table 119. T&W Group Recent Developments/Updates
 Table 120. Huilun Pharmaceutical Co., Ltd Company Information
 Table 121. Huilun Pharmaceutical Co., Ltd Description and Business Overview
 Table 122. Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Huilun Pharmaceutical Co., Ltd Tenofovir Fumarate Product
 Table 124. Huilun Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 125. Hefei Topway Biotechnology Co., Ltd Company Information
 Table 126. Hefei Topway Biotechnology Co., Ltd Description and Business Overview
 Table 127. Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hefei Topway Biotechnology Co., Ltd Tenofovir Fumarate Product
 Table 129. Hefei Topway Biotechnology Co., Ltd Recent Developments/Updates
 Table 130. Supor Pharmaceutical Co., Ltd Company Information
 Table 131. Supor Pharmaceutical Co., Ltd Description and Business Overview
 Table 132. Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Supor Pharmaceutical Co., Ltd Tenofovir Fumarate Product
 Table 134. Supor Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 135. Qilu Pharmaceutical Co., Ltd Company Information
 Table 136. Qilu Pharmaceutical Co., Ltd Description and Business Overview
 Table 137. Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Qilu Pharmaceutical Co., Ltd Tenofovir Fumarate Product
 Table 139. Qilu Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 140. Carelife Pharmaceutical Co., Ltd Company Information
 Table 141. Carelife Pharmaceutical Co., Ltd Description and Business Overview
 Table 142. Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Carelife Pharmaceutical Co., Ltd Tenofovir Fumarate Product
 Table 144. Carelife Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 145. Anke Hengyi Pharmaceutical Co., Ltd Company Information
 Table 146. Anke Hengyi Pharmaceutical Co., Ltd Description and Business Overview
 Table 147. Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Anke Hengyi Pharmaceutical Co., Ltd Tenofovir Fumarate Product
 Table 149. Anke Hengyi Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Tenofovir Fumarate Distributors List
 Table 153. Tenofovir Fumarate Customers List
 Table 154. Tenofovir Fumarate Market Trends
 Table 155. Tenofovir Fumarate Market Drivers
 Table 156. Tenofovir Fumarate Market Challenges
 Table 157. Tenofovir Fumarate Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tenofovir Fumarate
 Figure 2. Global Tenofovir Fumarate Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tenofovir Fumarate Market Share by Type: 2024 & 2031
 Figure 4. 30 Pcs/Box Product Picture
 Figure 5. 10 Pcs/Box Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Tenofovir Fumarate Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Tenofovir Fumarate Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Scientific Research Institutions
 Figure 11. Global Tenofovir Fumarate Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tenofovir Fumarate Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Tenofovir Fumarate Sales (2020-2031) & (Units)
 Figure 14. Global Tenofovir Fumarate Average Price (US$/Unit) & (2020-2031)
 Figure 15. Tenofovir Fumarate Report Years Considered
 Figure 16. Tenofovir Fumarate Sales Share by Manufacturers in 2024
 Figure 17. Global Tenofovir Fumarate Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Tenofovir Fumarate Players: Market Share by Revenue in Tenofovir Fumarate in 2024
 Figure 19. Tenofovir Fumarate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Tenofovir Fumarate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Tenofovir Fumarate Sales Market Share by Country (2020-2031)
 Figure 22. North America Tenofovir Fumarate Revenue Market Share by Country (2020-2031)
 Figure 23. United States Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Tenofovir Fumarate Sales Market Share by Country (2020-2031)
 Figure 26. Europe Tenofovir Fumarate Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Tenofovir Fumarate Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Tenofovir Fumarate Revenue Market Share by Region (2020-2031)
 Figure 34. China Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Tenofovir Fumarate Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Tenofovir Fumarate Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Tenofovir Fumarate Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Tenofovir Fumarate Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Tenofovir Fumarate Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Tenofovir Fumarate by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Tenofovir Fumarate by Type (2020-2031)
 Figure 53. Global Tenofovir Fumarate Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Tenofovir Fumarate by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Tenofovir Fumarate by Application (2020-2031)
 Figure 56. Global Tenofovir Fumarate Price (US$/Unit) by Application (2020-2031)
 Figure 57. Tenofovir Fumarate Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Tenofovir Disoproxil Fumarate Tablets Market Research Report 2024
Global Tenofovir Alafenamide Fumarate API Market Research Report 2025
Global Tenofovir Alafenamide Fumarate Market Research Report 2025
Tenofovir Alafenamide Fumarate Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Emtricitabine and Tenofovir Disoproxil Fumarate Tablets Market Research Report 2024
Global Nelfinavir Market Research Report 2024
Global Tenofovir Disoproxil Fumarate Market Research Report 2024
Global Tenofovir Disoproxil Fumarate API Market Research Report 2025
Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Research Report 2024
Tenofovir Disoproxil Fumarate Drug Substance Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lamivudine Drugs Market Research Report 2024
Global Antiviral API Lamivudine TDF and TAF Market Research Report 2024
Global Antiretroviral Drug Market Insights Forecast to 2030
Global Anti retroviral APIs Market Research Report 2024
Global Enfuvirtide for Injection Market Research Report 2024
Global Oral Anti HBV Drugs Market Research Report 2024
Global Zidovudine Market Insights Forecast to 2030
Global Oral Adefovir Drugs Market Research Report 2024
Global Zidovudine API Market Research Report 2025
Global Tenofovir Emtricitabine Combination Drug Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions